Evelo Biosciences, Inc. — Form D/A
Evelo Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2018-02-12. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-02-12
- Form: D/A
- Accession: 0001140361-18-006578
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 11
- Date of first sale: 2017-01-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-278687
Issuer
- Name: Evelo Biosciences, Inc.
- CIK: 0001694665
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 620 MEMORIAL DRIVE, CAMBRIDGE, MA, 02139
- Phone: 617 870 8281
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Noubar B Afeyan, Ph.D. | Director | Cambridge, MA |
| William P DeVaul | Executive Officer | Waltham, MA |
| David R Epstein | Director | Cambridge, MA |
| DAVID A BERRY, M.D., PH.D. | Director | CAMBRIDGE, MA |
| Jennifer P Glennon | Executive Officer | Cambridge, MA |
| Balkrishan (Simba) B Gill, Ph.D. | Director | Cambridge, MA |
| Balkrishan (Simba) B Gill, Ph.D. | Executive Officer | Cambridge, MA |
| Lord Ara P Darzi | Director | Cambridge, MA |
| Duncan P McHale | Executive Officer | Cambridge, MA |
| David P Perry | Director | Cambridge, MA |
| Mark P Bodmer, Ph.D. | Executive Officer | Cambridge, MA |
| Theodose B Melas-Kyriazi | Director | Cambridge, MA |
| Theodose A Melas-Kyriazi | Director | Cambridge, MA |
| Balkrishan (Simba) A Gill, Ph.D. | Director | Cambridge, MA |
| Balkrishan (Simba) A Gill, Ph.D. | Executive Officer | Cambridge, MA |
| Jackie P Papkoff | Executive Officer | Cambridge, MA |
| Derek P Adams | Executive Officer | Cambridge, MA |
| Mark A Pruzanski | Director | Cambridge, MA |
Other filings by this issuer (3)
More